Catalyst Pharmaceuticals (CPRX) – Litigation
-
Catalyst Pharmaceuticals (CPRX) Receives Two New U.S. Patent Allowances For FIRDAPSE
-
Catalyst Pharmaceuticals (CPRX) commented on the FDA's notice setting forth its position on Orphan Drug Exclusivity
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CPRX Stock Lookup